Unvaccinated, Delta survivors have no protection against Omicron: Study

On the contrary, Covid survivors who were also fully vaccinated showed an increased ability to combat the strain

Omicron, Covid-19, Coronavirus
IANS London
2 min read Last Updated : Dec 22 2021 | 7:23 PM IST

While it is known that Covid infections give natural antibodies, a new study has shown that people who are unvaccinated but were previously infected by the Delta Covid variant may have very little protection against the new vaccine-evading Omicron.

To measure antibody levels, researchers from the Medical University of Innsbruck, in Austria, compared the blood of those who had beaten Delta against Omicron, Daily Mail reported.

Only one out of seven samples produced enough of the infection-fighting proteins to neutralise Omicron.

"This essentially means the antibodies did not recognise Omicron as a threat due to its heavily mutated nature compared to the Delta variant," the researchers said.

On the contrary, Covid survivors who were also fully vaccinated showed an increased ability to combat the strain, suggesting that prior infection alone offers virtually no protection against catching Omicron, the report said.

The team also tested two doses of the Pfizer jabbed with Omicron and found that it fared better - nine out of 20 samples produced enough antibodies to fight off the new Covid variant before it caused infection.

A similar test for two doses of the Moderna jab showed only one out of 10 was successful in generating antibodies against Omicron, the report said.

Overall, the best results were found in five samples taken from those who had both survived a previous Covid infection and then later got a vaccine - a group of people the researchers dubbed the 'super-immune', the report said.

Although the study has small numbers, it added to research demonstrating Omicron's ability to dodge immunity, Professor Lawrence Young, a microbiologist from the University of Warwick in the UK was quoted as saying.

He stated it was "dangerous" to infer any findings from the study, and added that the study reinforced the importance of getting a booster.

"It's dangerous to extrapolate what this data means for immune protection in vaccinated individuals other than reinforcing the value of booster vaccination - which is likely to be similar to the super immune individuals in this study," Young noted.

--IANS

rvt/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusVaccinationDelta

First Published: Dec 22 2021 | 7:23 PM IST

Next Story